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Abstract
Background: Down syndrome (DS), caused by trisomy of human chromosome 21 (HSA21), is
the most common genetic birth defect. Congenital heart defects (CHD) are seen in 40% of DS
children, and >50% of all atrioventricular canal defects in infancy are caused by trisomy 21, but the
causative genes remain unknown.
Results: Here we show that aberrant adhesion and proliferation of DS cells can be reproduced
using a transchromosomic model of DS (mouse fibroblasts bearing supernumerary HSA21). We
also demonstrate a deacrease of cell migration in transchromosomic cells independently of their
adhesion properties. We show that cell-autonomous proteome response to the presence of
Collagen VI in extracellular matrix is strongly affected by trisomy 21.
Conclusion: This set of experiments establishes a new model system for genetic dissection of the
specific HSA21 gene-overdose contributions to aberrant cell migration, adhesion, proliferation and
specific proteome response to collagen VI, cellular phenotypes linked to the pathogenesis of CHD.
Background
Down syndrome (DS), a congenital condition caused by
the trisomy of human chromosome 21 (HSA21), is the
most frequent chromosomal abnormality in live births
associated with mental retardation and congenital heart
defect (CHD) [1]. Although the pathology of DS is associ-
ated with a number of complex manifestations [1-3], the
presence of a congenital heart defect (CHD) is the greatest
risk factor for death during infancy. Approximately 40%
of liveborn DS infants are born with a CHD [4], the
majority of which involve abnormal development of the
atrioventricular canal (AVC). Although CHD occur as iso-
lated abnormalities in otherwise normal children, >50%
of AVC defects are diagnosed in DS infants [5]. The asso-
ciation between DS and AVC defects has led to specula-
tion that proteins encoded on chromosome 21 are
involved in cardiac valve development. Molecular mecha-
nisms responsible for the development of AVC defects are
not known, and their protein cause has not yet been
firmly assigned to trisomic contributions of specific
HSA21 genes. A currently accepted stochastic model [6]
predicts that increased cell adhesion causes the decreased
migration of trisomy 21 cells preventing normal AVC for-
mation. The crucial underlying process is the cellular
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response to changes in extracellular matrix, which can
also trigger epithelial-mesenchymal transformation
(EMT) [7], the developmental process thought to be
responsible for heart valve and septa development [8].
Jongewaard et al. have compared integrin-mediated cell
adhesive properties for skin fibroblasts isolated from DS
and non-DS individuals on fibronectin (FN) and type I
and VI collagen (Col I and Col VI) [9]. While cells demon-
strated similar adhesion profiles to FN and Col I, all DS
fibroblasts displayed an aberrantly increased adhesive
capacity for Col VI compared to non-DS fibroblasts. Col
VI, encoded on HSA21, is a component of the extracellu-
lar matrix that is speculated to anchor cells within the
three dimensional tissue space through binding to cell
surface integrins and other structural matrix components
[10]. During heart development, Col VI is expressed
within the endocardial cushions and the developing AVC
in a pattern that parallels cell migration and septum-valve
remodelling [11-13]. Though molecular screening of fam-
ilies with DS infants had demonstrated an association
between genetic variations in the collagen VI (Col VI)
region and AVC defects [14], the trisomy of the Col VI
gene alone has been ruled out as the cause of CHD in DS
by two reports: (i) studies of correlation of partial triso-
mies of HSA21 with the occurrence of CHD narrowed
down a region containing some 20% of HSA21 genes, but
excluding ColVI [15]; and (ii) a ColVI transgenic mouse
model showed no abnormalities in heart development
[16]. Therefore, other approaches are needed to examine
the contribution of HSA21 proteins in the CHD-critical
region to the pathogenesis of CHD.
Here we show that increased DS cell adhesion to ColVI as
matrix, aberrant proliferation of adhering DS cells, and
aberrant cell migration (independent of adhesion) can all
be reproduced in a transchromosomic model of DS
(mouse fibroblasts a bearing supernumerary human chro-
mosome 21) [14]. Transchromosomic models of DS offer
a further advantage of the possibility of specific transcrip-
tional silencing of a single gene from the supernumerary
human chromosome while maintaining the trisomic
expression of all other HSA21 genes [17], thereby assign-
ing the causative genetic contribution for a phenotype to
the trisomic overdose of a single HSA21 gene [17]. We
show that trisomy 21 cells, to a much greater degree than
normal controls, acquire SELDI-TOF-MS detectable pro-
teome changes specific to the presence of collagen VI as
adhesion matrix. Our data provide an indication, at the
proteomic level, that trisomy 21 affects the cell-autono-
mous proteome response to the change in the extracellu-
lar matrix composition. This set of experiments also
establishes a cellular model system capable of dissecting
the specific HSA21 gene-overdose contributions to aber-
rant cell migration, adhesion, and the proteome response
to collagen VI, potentially advancing the understanding of
molecular mechanisms behind the pathogenesis of CHD.
Results
Presence, integrity and expression of HSA21 in the 
transchromosomic cell WA17
In this study, we used the transchromosomic mouse-
human hybrid cells, WA17, which contain a supernumer-
ary human chromosome 21 (HSA21) and are derived
from a hybrid cell line obtained by fusion of mouse A9
cells with human WI-38 fibroblasts [18]. In order to con-
firm the presence of HSA21 in our model, we performed
a PCR using human specific primer sets for markers/genes
in different regions of HSA21. All four tested markers spe-
cifically amplified WA17, but not A9 DNA, establishing
the presence of HSA21 (Fig 1A). Next, we examined the
integrity of the genetic material in the cell lines used, to
exclude any structural and copy number changes occur-
ring during cell line establishment/propagation. The
integrity of the supernumerary HSA21 in WA17 cells was
examined using hybridisation to the HSA21 specific high-
resolution Nimblegen arrays (HG18 CHR21 FT Chrom-
some 21 Tiling Array). This analysis showed (Fig 1B) that
all segments of HSA21 were present in equal dose, ruling
out any deletions or duplications of HSA21 down to the
resolution of 3500 bp. Also, the lack of any copy number
rearrangements of the mouse genome between the WA17
and their parental control A9 cell lines was verified using
hybridisation to MM8 WG CGH Whole Genome Tiling
Arrays, where no rearrangements were seen (Fig 1B). In
addition, to confirm the expression of human proteins
encoded on HSA21, the A9 and WA17 cell extracts were
immunoblotted using a polyclonal a-SOD1 antibody
raised against both the human and mouse SOD1 (Fig 1C).
Using this antibody, we compared expression of SOD1 in
the human cell line HEK 293 to WA17 and A9 cell lines.
As expected, both mouse and human SOD1 proteins were
detected in WA17 cell line (Fig 1C). Therefore, the "qual-
ity-control" experiments demonstrated the presence,
integrity and expression of HSA21 in the transchromo-
somic cell WA17 (Fig 1A, B and 1C).
Aberrant migration, adhesion and proliferation in a 
transchromosomic cell model of DS
A stochastic scenario determined by computer modelling
[6] predicted that increased adhesion causes the decreased
migration of trisomy 21 cells preventing normal endocar-
dial cushion closure and AVC formation. Decreased cell
migration has never been, to our knowledge, previously
assayed in vitro in DS cells. We decided to quantitate cell
adhesion to uncoated culture dish surface using the stand-
ard assay, and cell migration using the monolayer-scratch
assay [19,20]. Cells were pre-treated with mitomycin-C to
stop cell divisions. As can be seen in Fig 2A and 2B, the
monolayer-scratch assay showed that the number of cells
that migrated was significantly reduced for WA17 cells
compared to control cells (A9). Quantitation of these data
is shown in Fig 2B, where the percentage of migrating A9
and WA17 cells at day 1, 2 and 3 after wounding the cell
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monolayer is calculated. These assays indicated that defec-
tive fibroblast migration can indeed be demonstrated for
DS-model cells in vitro. There was no difference in the
level of cell adhesion to uncoated dish surface between
the WA17 and A9 cells (data not shown). Therefore, the
further novel conclusion from these data is that the
decreased cell migration is a stand-alone cellular pheno-
type, not accompanied by increased cell adhesion to the
same surface in which both assays were performed.
Characterization of the integrity of the WA17 cell line model of DSFigure 1
Characterization of the integrity of the WA17 cell line model of DS. (A) Total DNA extracted from A9 and WA17 
cells was subjected to PCR analysis using human-specific primers for D21S212, USP25, RUNX1, Mir155 and mouse Krt19 
primers as described in Materials and Methods. (B) Ultra high resolution array CGH hybridisation of the WA17 against A9 
genomic DNA to the ultra high resolution NimbleGen HG18 chromosome 21 specific 385K arrays show the presence of the 
full length of HSA21 with no cryptic deletions or duplications. A 50× averaging window was also calculated, resulting in 3500 bp 
segments for this array. The lack of copy number rearrangements of the mouse genome between the WA17 and their parental 
control A9 cell lines was verified using MM8 WG CGH Whole Genome Tiling Arrays. Data were visualized in SignalMap V1.9 
software (Roche NimbleGen, Wisconsin, USA). Averaging windows were used for breakpoint determination. (C) The total cell 
lysates of HEK 293, A9 and WA17 cells were immunoblotted with an anti-SOD1 polyclonal antibody. The mouse SOD1 
(Mouse) and human SOD1 (Human) are indicated by arrows.
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It has been previously demonstrated that fibroblasts
explanted from the skin of DS and non-DS individuals
differ in their adhesion properties to different compo-
nents of the extracellular matrix (ECM). They had similar
adhesion profiles to fibronectin (FN) and collagen I (Col
I), but all DS cells displayed increased adhesive capacity
for collagen VI (Col VI) compared to non-trisomic fibrob-
lasts [9]. Col VI is an HSA21 gene, it is expressed in the
developing AV canal extracellular matrix and it is overex-
pressed in DS skin tissue [21]. In order to attempt repro-
ducing these results in the transchromosomic model of
DS, A9 and WA17 cells were plated on FN or Col VI in the
same conditions as previously published for fibroblasts
explanted from DS donor individuals [9]. The adherence
efficiency was defined by calculating the number of cells
that remained attached. We confirmed that the propor-
tion of WA17 cells adhering to ColVI was significantly
increased compared the cells adhering to FN (Fig 3A). The
same comparison for normal (A9) cells showed no differ-
ence (Fig 3A), fully reproducing the adhesion results from
DS skin fibroblast donors [9]. Since adhesion of trisomic
cells to Col VI was increased, we decided to examine the
effects of the ECM type on cell proliferation. As expected,
we observed a great difference in cell proliferation rates
between the two cell lines, A9 and WA17 (Fig 3B). The
WA17 cells had a significantly reduced proliferation rate
compared to normal (A9) cells, on both adhesion matri-
ces (FN and ColVI). This finding is in full concordance
with the results obtained with cultured fibroblasts from
DS donors, which had a significantly slower proliferation
rate compared to fibroblasts of normal donors [22]. Inter-
estingly, the presence of Col VI as adhesion matrix, as
compared to FN, provoked a statistically significant
increase in the proliferation rate of WA17, but not of A9
cells (approximately 10%).
In conclusion, we found that transchromosomic DS-
model cells showed adhesion-independent defective
migration on an uncoated surface, and reproduced the
cellular phenotypes observed in fibroblasts from the skin
of DS individuals: slower proliferation rate compared to
normal cells and aberrantly increased adhesion to Col VI.
In addition, trisomic cells proliferated slightly faster on
Col VI than on FN, a phenotype not shared by euploid
cells.
Effect of adhesion matrix type on the proteomic profile of 
DS-model and normal cells
As the ECM in DS contains a higher dose of ColVI [21], it
could provide signals inducing a response in cells, irre-
spective of the trisomy of HSA21 (the so called "outside-
in" signalling perturbation [9]). On the other hand, over-
dose of HSA21 proteins could perturb the signalling in a
cell-autonomous way, caused by the increased dose of
specific unknown HSA21 proteins (the "inside-out" sig-
nalling perturbation) [9]. In order to estimate the degree
to which these two conceptual mechanisms play a role in
DS cells, we sought a rapid method to detect changes in
the proteome composition of the cells cultured on two
adhesion matrices, ColVI and FN.
We first cultured WA17 and A9 cells for 3 days, resolved
protein extracts by SDS-PAGE and stained with coomassie
blue. A reproducible separation of the protein extracts
showed SDS-PAGE patterns gave no obvious differences
(Fig 4A), showing that there are no pleiotropic alterations
of abundant proteins between A9 and WA17 cells.
We then analysed protein extracts from each cell line (A9
and WA17) on the ProteinChip system (Ciphergen Bio-
systems, Fremont, CA), which is based on the integration
of chemically modified array surfaces with surface-
enhanced laser desorption/ionization (SELDI) time-of-
flight (TOF) mass-spectrometry (MS) detection [23]. This
technology was chosen as the immediate goal of our
experimental approach was not the identification of
biomarkers, but merely a rapid detection of a cell autono-
mous response to the changes in the composition of ECM,
and the influence (if any) of trisomy 21 on this response.
Protein profiles of the A9 cell line were measured on four
different chemically modified array surfaces: H50, IMAC,
Q10, and CM10 arrays by SELDI-TOF-MS. Spectra of pro-
tein extracts (2 μg protein per spot) revealed about 50-150
peaks per array type (Fig 4B). As expected, due to specific
Cell migration of the WA17 cell line model of DSFigure 2
Cell migration of the WA17 cell line model of DS. (A) 
A9 and WA17 cells were grown until confluent, and treated 
with 10 mg/ml mitomycin C for 2 h, before a scratch wound 
was introduced using a yellow pipette tip. Cells were then 
incubated for 3 days in normal growth media. Pictures were 
taken at 0, 1, 2 and 3 days after wounding. (B) Pictures from 
4 non-overlapping scratch wounds of each of 3 independent 
cultures (n = 12 data points for each cell line) from part A 
were taken and cells migrated into the wound site were 
quantified (Open bars A9, filled bars WA17). Data are pre-
sented as mean ± SD (**p < 0.001 t-test comparing A9 versus 
WA17).
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binding affinities of the chromatographic surfaces used,
different portions of the A9 proteome were retained and
detected on different surfaces. Highest peak numbers and
densities were achieved on the arrays Q10 and CM10. In
an attempt to determine the optimum amount of spotted
protein for SELDI profiling, we have used a range of pro-
tein quantities (2, 1, 0.5 and 0.1 μg) per spot of an array,
of A9 cell lysate (Fig 4C). From these experiments, the
highest peak numbers were achieved on the array Q10 for
2 μg of protein (Fig 4C). Next, samples were profiled on
Q10 with 100 mM Tris-HCl of varying pH range (pH 6-9)
with 0.5% Triton X-100. The optimal condition was pH 8
(data not shown). Subsequently, samples were assessed at
pH 8 on Q10 chip, which allows selective binding of com-
patible proteins with an isoelectric point of 7 or below.
Therefore, measurements were repeated on Q10 with
samples of 4 independent cultures of WA17 and A9 cells
used for profile analysis with 2 μg/spot at pH 8. Plots of
PCA scores, based on SELDI spectra, showed a clear differ-
entiation between the A9 and WA17 cell lines (Fig 5A).
Moreover, heat map visualisation of A9 and WA17 cells
revealed a clear separation by unsupervised hierarchical
clustering of the two major subgroups: DS-model (WA17)
and normal control (A9) (Fig 5B). These results demon-
strate that there is a clear global alteration of protein
expression pattern between A9 and WA17 cells.
Proteins lysates from A9 and WA17 cells cultured in the
presence of FN or Col VI for 72 h (n = 7 for each condi-
tion) were allowed to bind to the Q10 surface (binding in
0.1 M phosphate buffer, pH 8 supplemented with 0.1%
triton X-100), and analysed by SELDI-TOF. A total of 118
peaks were detected on the Q10 surface, with 96 peaks in
the range if 2-30 kDa, when peak definition criteria were
set to S/N-ratio of 3 or more and peak threshold set to
25% of spectra. From this group, 31 peaks were signifi-
cantly differentially expressed (p < 0.05; Table 1). For
these peaks the intensity levels were compared for each of
the two culture conditions to search for differentially rep-
resented proteins, or compared for cell type (Table 1). The
comparison Col VI versus FN, in the Fig 6A and 6B,
showed WA17 cells had more ECM-regulated proteins
(~50%, diagram right) than A9 cells (~30%, diagram left).
This result is the first demonstration that the inside-out
signaling is at least as important as the outside-in signal-
ing in explaining the aberrant response of DS cells to the
ECM composition.
Proteomic versus phenotypic profiles of A9 and WA17 cells
We have investigated proteomic profiles in 4 independent
cell cultures of A9 and WA17 in absence of ECM (Fig 5),
and in 7 independent cell cultures of A9 and WA17 in
presence of Col VI or FN (Table 1 and Fig 6). In order to
visualize the effects of the response of A9 and WA17 cells
cultured in presence or absence of Col VI or FN, a princi-
pal component analysis (PCA) was performed on the pat-
tern of intensities of the 31 significant peaks (Fig 7A). Two
important conclusions can be drawn from the results of
such analysis. Firstly, samples from cells cultured in pres-
ence of Col VI and FN clustered differently from cells cul-
tured in absence of ECM, verifying that cellular proteome
response to ECM is reproducibly detected by the SELDI-
TOF MS analysis. Secondly, proteomic profiles from 14
independent WA17 samples separated into two distinct
clusters due to differences in ECM-type (FN or Col IV)
while the 14 independent A9 samples projected into a sin-
gle cluster (Fig 7A). Thus, for the proteomic profiles, we
observed clear clustering driven by the presence of the
supernumerary HSA21 and correlating with the cell adhe-
sion properties of the two cell lines.
Next, we examined the phenotypic profiles (cell prolifera-
tion and cell adhesion), to visualize the effects of the
response of A9 and WA17 cells cultured in presence or
absence of Col VI or FN, on the cell proliferation and cell
adhesion (Fig 7B). For the A9 cells, those cultured in the
presence of FN co-clustered with those cultured in the
presence of Col VI (Fig 7B). Interestingly, for WA17 cells,
those cultured on FN clustered separately from those cul-
tured on ColVI (Fig 7B). Thus, we observed a very good
correlation between the cell adhesion/growth properties
and their proteomic profile clustering.
Discussion
Hypothetical paradigms for the molecular origins of DS
phenotypes include the gene non-specific developmental
instability model and the specific HSA21 gene overdose
Cell adhesion and proliferation of the WA17 cell line model of DSFigure 3
Cell adhesion and proliferation of the WA17 cell line 
model of DS. (A) Plates were coated with FN (5 μg/ml) or 
Col VI (10 μg/ml). A9 (open bars) and WA17 (gray filled 
bars) cell lines (n = 12 independent cultures for each cell line 
and each ECM condition) were allowed to adhere to the 
protein coated plates for 60 minutes. Adhesion assays were 
performed as described in Materials and Methods. The per-
centage of adherent cells are shown as mean ± SD. (**p < 
0.001 T-test comparing FN and Col VI conditions for WA17). 
(B) Proliferation assay was performed as described in Materi-
als and Methods, on plates coated with ColVI and FN, as 
above. Data represent the means ± SD (*p < 0.01 T-test 
comparing FN and Col VI conditions for WA17).
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model [2,24,25]. Several single HSA21 gene overdose
models have been linked to phenotypic traits of DS in
transgenic mice [26-29] (SOD, ets2, SIM2, DYRK1A), but
these models examine a single gene-overdose at a time,
without the context of the trisomy of all other genes on
the chromosome. Transchromosomic models of DS
[18,30,31], constructed by introducing a supernumerary
HSA21 into a normal mouse cell, have produced a first
mouse with a human chromosome, the most complete
HSA21 trisomy model, displaying a range of DS-like phe-
notypes, including the congenital AVC defect [32]. Tran-
schromosomic models of DS offer a further advantage of
Representative SELDI-TOF MS spectra from A9 samplesFigure 4
Representative SELDI-TOF MS spectra from A9 samples. (A) A9 and WA17 cells were lysed and proteins resolved by 
SDS-PAGE. Equal amounts of total protein lysate were used for electrophoresis (20 μg). (B) An example of SELDI protein-pro-
filing spectra of 2 μg of whole cell protein extract of A9 cell line on four different chromatographic arrays (H50, IMAC, Q10 
and CM10) is shown. (C) A dilution series of A9 cell protein extract sample was prepared and 2 μl of each was analyzed on a 
Q10 and CM10 ProteinChip array. The total amount of protein analyzed was 2, 1, 0.5 and 0.1 μg, respectively.
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the possibility of specific transcriptional reduction-to-dis-
omy of a single gene from the supernumerary human
chromosome while maintaining the trisomic expression
of all other HSA21 genes [17].
In this study, we establish within a pair of cell lines of a
transchromosomic model of DS the two main cellular
phenotypes (i.e. decreased cell migration, increased adhe-
sion to Col VI) relevant to the current hypothetical model
for the pathogenesis of AVC in DS. A stochastic model [6]
had been previously proposed to explain how alterations
in the properties of developing endocardial cells could
control the formation of endocardial cushions in normal
persons, in subjects either from families with a predispo-
sition to congenital heart defects, or with trisomy 21. Nor-
mal and abnormal outgrowth of the endocardial cushions
of the atrioventricular (AV) canal were modeled by com-
puter simulations. Computer simulations illustrated how
decreased cellular migration and increased cellular adhe-
siveness of fibroblasts from the endocardial cushions of
the AV canal in Down syndrome may result in AV canal
defects [6]. It has been demonstrated that skin fibroblasts
explanted from DS individuals displayed increased adhe-
sion on Col VI [9], a component of the ECM expressed in
the developing AVC [11,12]. By examining cell adhesion
to purified extracellular matrix components following a 1-
hour incubation period, the current study compared the
adhesion properties of WA17 (transchromosomic) and
A9 (non-trisomic fibroblasts) cell lines (Fig 3A). Cell lines
demonstrated similar adhesion profiles on FN, but WA17
cells displayed increased adhesive capacity for Col VI
compared to A9 cells (Fig 3A). Although WA17 fibroblasts
are not equivalent to embryonic AV canal tissues [33],
they represent a reasonable alternative to begin compar-
ing molecular and cellular processes in DS and non-DS
tissues. Indeed, our results reproduced the adhesion prop-
erties of skin fibroblasts from DS subjects [9]. In addition,
we establish, for the first time in a DS model, a phenotype
of defective cell migration (which was predicted by a com-
puter simulation for the stochastic Kurnitt model, [6]).
Surprisingly, we show that this migration defect does not
seem to be caused by the increased adhesion of the cells;
on uncoated culture dish surface (where our scratch assay
found decreased migration of DS-model cells, Fig 2A and
2B), the WA17 cells adhered as efficiently as the A9 cells
(data not shown). This is a new insight, and it allows to
speculate that perhaps the two defects are independent of
each other, hence might be caused by different mecha-
nisms, and that different HSA21 genes (or groups of
genes) in trisomy might be causing decreased migration,
whereas other genes may be causing the increased adhe-
sion to ColVI, but both (sets of) genes might be required
for the AVC defect to develop. This hypothesis gives even
more importance to modeling both phenotypes in a tran-
schromosomic system, where human-specific gene silenc-
ing could correct individual gene(s) expression to disomy,
while maintaining the trisomic status of the rest of HSA21
[17], and thus help dissect the individual gene(s) contri-
butions to each of the two phenotypes.
Several studies have shown a diminished rate of cellular
proliferation in fibroblasts from Down syndrome com-
pared to normal donors [22,34,35]. In Fig 3B, we showed
that this defective proliferation is maintained in the tran-
schromosomic fibroblast cell line WA17, irrespective of
the adhesion matrix (FN or ColVI). Interestingly, we show
that adhesion to Col VI stimulated the proliferation of
WA17 cells. To our knowledge, it had never been reported
that the adhesion onto a Col VI matrix increased the pro-
liferation of DS cells, and this effect could be another fac-
tor to consider occurring during the abnormal
development of the AV canal in DS.
The SELDI-TOF peak profile of the normal cells (A9)
showed a 30% difference when grown on ColVI com-
pared to FN as the adhesion matrix. This shows that the
composition of the ECM, especially in DS where the ECM
content of ColVI is higher, may influence the protein
expression ("outside-in" signaling). However the compar-
ative data on the DS-model cells (WA17) show that a
much larger upheaval of the proteome (close to 50%) is
influenced by the adhesion matrix type. This demon-
Proteins profiles of A9 and WA17 cell linesFigure 5
Proteins profiles of A9 and WA17 cell lines. (A) The 
intensity of peaks from SELDI spectra were analyzed using 
the PCA algorithm (CiphergenExpress software). A 3D PCA 
scores plot indicates clusters of A9 (in red) and WA17 (in 
blue) cell lines. (B) The heat-map view provides an at-a-
glance view of spectra and their relative expression levels. 
Red indicates enhanced expression and green indicates 
reduced expression whereas black means no change in 
expression. The dendrogram displays clusters of spectra 
based on similarity of their profiling patterns. The clustering 
analysis indicates a separation into two main groups, namely 
the profiles of A9 and WA17 cell lines.
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SELDI-MS analysis of A9 and WA17 cells grown on FN or Col VIFigure 6
SELDI-MS analysis of A9 and WA17 cells grown on FN or Col VI. Cells were grown in presence of FN (5 μg/ml) or 
Col VI (10 μg/ml). Cells were then lysed and protein profiles were generated by SELDI-TOF MS using the Q10 array. (A) Spec-
tral view for A9 cells in presence of FN or Col VI. Diagram summarizes the response of A9 to Col VI versus FN. (B) Same 
experiments were repeated for WA17 cell line. Significant differences in peak intensity up- (↑) and down- (↓) regulated in 
ColVI vs FN comparison and "NS" for no significant difference.
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strates that the "inside-out" signaling is equally signifi-
cant, i.e. the specific response to the change in the ECM
composition is heavily affected by the increased dose of
HSA21 genes. This suggests that the function of one or
more HSA21 proteins is linked to the adhesion properties
and the cellular response to the ECM stimuli. This is
potentially a very important new insight, because the cel-
lular response to changes in extracellular matrix can also
trigger epithelial-mesenchymal transformation (EMT) [7],
the developmental process thought to be responsible for
heart valve and septa development [8]. The list of peaks
showing a change in intensity or presence (Table 1) when
ColVI is introduced instead of FN, can be reproducibly
modeled in this system (Fig 6 and 7), offering the possi-
bility to dissect the contributions of individual HSA21
genes within the trisomy to the specific proteomic
changes. More in-depth studies are needed to identify the
proteins behind these peaks, using electrospray nano-LC-
MS/MS and related approaches. The overdosed HSA21
genes causing the adhesion and proliferation differences
may be similar or same to the ones causing the proteome
perturbation, as suggested by the data in Fig 7, where dif-
fering proteomic peaks of the DS-model cells (unlike
those of normal cells) split into two clusters, one grown
on FN and one grown on ColVI, and so did their pheno-
typic profile, based on adhesion plotted against the prolif-
eration.
Conclusion
In this study, we show that increased DS cell adhesion to
ColVI as matrix, aberrant proliferation of adhering DS
cells, and aberrant cell migration (independent of adhe-
sion) can all be reproduced in a transchromosomic model
Table 1: Cell proteins found on Q10 surface using SELDI-TOF 
MS.
COL6 vs. FN WA17 vs. A9
Protein mass (Da) A9 WA17 Col6 FN
2928.711474 ↑ ns ↑ ↑
4703.857024 ns ns ↑ ns
4981.209087 ns ↓ ↓ ↓
5679.754004 ns ns ↓ ns
6114.720974 ↓ ns ns ns
8103.058978 ↓ ↓ ns ns
8312.547561 ↓ ↓ ns ns
8441.626517 ↓ ↓ ns ns
9903.636707 ns ↓ ↓ ↓
10213.32293 ns ↓ ↓ ↓
10422.68469 ns ↓ ↓ ↓
10469.92325 ns ns ns ↑
11029.05511 ns ns ↓ ↓
11213.49186 ↑ ↓ ns ↑
11592.0861 ns ns ↓ ns
11787.84126 ns ↑ ns ns
14764.39772 ns ↓ ↑ ↑
14868.10077 ns ↓ ns ↑
16795.05992 ↓ ↓ ns ns
16975.61298 ↓ ↓ ↑ ns
17144.40172 ↓ ↓ ↑ ns
17710.57534 ↓ ns ↑ ↑
19940.69626 ns ↓ ↓ ↓
20990.77856 ↑ ns ↓ ns
23283.49199 ns ns ↓ ↓
29302.71775 ns ↓ ns ↑
32146.69417 ↓ ns ns ns
34916.22347 ns ns ↓ ↓
57962.25434 ns ns ↑ ns
66566.11805 ns ↑ ↑ ↑
80036.67172 ns ns ↑ ns
Significant (p < 0.05, ANOVA with Fisher's post hoc test) up (↑) and 
down (↓) peak intensity differences in Col VI compared to FN are 
noted. The "ns" denotes no significant differences.
Proteomic and Phenotypic profiles of A9 and WA17 cell linesFigure 7
Proteomic and Phenotypic profiles of A9 and WA17 
cell lines. (A) WA17 and A9 cell lines were grown in pres-
ence (n = 14 experiments for each cell line) or absence (n = 
4 experiments for each cell line) of Col VI or FN and protein 
profiles were generated by SELDI-TOF MS using the Q10 
array. A correlation biplot of PCA components 1 and 2 is 
shown (CiphergenExpress software). (B) Plates were coated 
or not coated with FN or Col VI. Cell adhesion was analyzed 
on the X axis (n = 12 experiments for each data point) and 
cell proliferation on the Y axis (n = 12 experiments for each 
data point). Adhesion and proliferation assays were per-
formed in the same conditions as for the data in figure 3.
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of DS (WA17) [14]. Transchromosomic models of DS
offer a further advantage of the possibility of specific tran-
scriptional silencing of a single gene from the supernu-
merary human chromosome while maintaining the
trisomic expression of all other HSA21 genes [17], thereby
assigning the causative genetic contribution for a pheno-
type to the trisomic overdose of a single HSA21 gene [17].
We show that trisomy 21 cells, to a much greater degree
than normal controls, acquire SELDI-TOF-MS detectable
proteome changes specific to the presence of collagen VI
as adhesion matrix. Our data provide an indication, at the
proteomic level, that trisomy 21 affects the cell-autono-
mous proteome response to the change in the extracellu-
lar matrix composition.
In conclusion, this set of experiments establishes a cellular
model system capable of dissecting the specific HSA21
gene-overdose contributions to aberrant cell migration,
adhesion, and the proteome response to collagen VI,
which could further inform the attempts to identify and
model the genetic cause of the pathogenesis of CHD in
DS.
Methods
Materials and Cell culture
Purified bovine Collagen VI (COL VI) and human
fibronectin (FN) were from Chemicon (Temecula, CA).
Bovine serum albumin (BSA) and other general reagents
and tissue culture media in this study were from Sigma
(Dorset, UK) unless otherwise stated. A9 and WA17 cells
[18], a kind gift of Prof. E.M. Fisher, were passed every
three days at 3 × 103 cells/cm2 in Dulbecco's Modified
Eagles Medium (DMEM) supplemented with 10% fetal
bovine serum and maintained in an atmosphere of 5%
CO2 humidified air at 37°C.
PCR analysis
Analysis of the presence of HSA21 in WA17 was carried
out using human-specific primer sequences: USP25-F
AGTAGCGAAACAGTGCATTAC, USP25-R GATGAGGT-
CACACCTGAATAG, MIR155b-F TACTATATGCTGT-
CACTCCAG, MIR155b-R AGGTTGAACATCCCAGTGAC,
RUNX-F AAGATGAAACGTGGAGA AATAG, RUNX-R
CTGGACATCACCCACGAGTG, D21S212-F CATTTTAAT-
GAACACCGCTC, D21S212-R GGCCTCCTGGAATAAT-
TCTC. Mouse keratin19 primers were used as positive
control: Krt19-F AACCGGAAGGATGCTGAAG, Krt19-R
GACTGCAGCTCAATCTCAAG. Programme 95°C 1 m 30
s, (95°C 30 s, 57°C 30 s, 72°C 30 s) 35 cycles, 72°C 9 m
30 s. For D21S212, the annealing temperature was 53°C.
Ultra-high resolution array CGH
For detailed structural HSA 21 aberration detection, high
resolution NimbleGen HG18 chromosome 21 specific
385K arrays were used, (B3752001-00-01; Roche Nimble-
Gen Systems, Madison, Wisconsin, USA). The 385K aver-
age probe distance was 70 bp. DNA labeling, array
hybridization, post-hybridization washes and scanning
were essentially performed according to the manufac-
turer's instructions (Roche NimbleGen, Madison, Wis-
consin, USA). The acquired images were analyzed using
NimbleScan V2.4 extraction software (Roche NimbleGen,
Wisconsin, USA). For each spot on the array, log2 Cy3/
Cy5 ratio, was calculated using the segMNT algorithm,
which also applied an automatic segment detection. The
relative intensity of the test sample (Cy3 labeled WA17)
vs. the reference DNA (Cy5 labeled A9 DNA) indicated on
a log2 scale. A positive result was determined when a
genomic segment complementary to oligonucleotide
probes for CNV (gain or loss) was 0.2 fold average differ-
ence from reference normal DNA. A 50× averaging win-
dow was also calculated, resulting in 3500 bp segments
for this array. Based on previous experiments (data not
shown), the few p-arm probes, as well as sub-centromeric
probes until genomic position 14.4 Mb were not consid-
ered in the analyses, due to repeat content (e.g. segmental
duplications). The lack of copy number rearrangements of
the mouse genome between the WA17 and their parental
control A9 cell lines was verified using MM8 WG CGH
Whole Genome Tiling Arrays. Data were visualized in Sig-
nalMap V1.9 software (Roche NimbleGen, Wisconsin,
USA). Averaging windows were used for breakpoint deter-
mination.
Cell Migration, Adhesion and Proliferation Assays
The in vitro scratch assay was performed using A9 and
WA17 cell lines to measure cell migration as previously
described [19]. A9 and WA17 cells were grown until con-
fluent, and treated with 10 mg/ml mitomycin C for 2 h,
before a scratch wound was introduced using a yellow
pipette tip. Cells were then incubated for 3 days in normal
growth media. Pictures were taken at 0, 1, 2 and 3 days
after wounding. Four non-overlapping scratch wounds of
each of 3 independent cultures (n = 12 data points for
each cell line) were microphotographed and cells
migrated into the wound site were quantified. Micro-
photographs were captured by Eclipse TE2000-S micro-
scope from Nikon and cells migrated into the wound site
were counted and presented as mean ± SD. Cell adhesion
assays were performed in absence or presence of Col VI
and FN (n = 12 independent cultures for each cell line and
each ECM condition) as previously described [9]. For cell
proliferation, cells were plated in 96-well dishes coated or
uncoated with purified extracellular matrix components
(ECM) ColVI or FN (n = 12 independent cultures for each
cell line and each ECM condition). Cell proliferation was
measured using a cell counter (NucleoCounter - Chem-
ometec).
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SDS-PAGE and Immunoblot
Cells were solubilized for 30 min on ice in buffer A (30
mM Tris-HCl pH 8.0, 150 mM NaCl, 1 mM PMSF, 1 mM
NaF, 1 μg/ml leupeptin, 5 KU/ml aprotinin containing
1.5% Triton-X100). The lysate was clarified by centrifuga-
tion at 435,000 × gmax for 30 min at 4°C. SDS-PAGE and
immunoblot analyses were performed as described previ-
ously [20].
Protein profiling by SELDI-MS TOF
After 3 days of culture in presence or absence of ECM, har-
vested cell pellets of A9 and WA17 lines were resuspended
in a lysis buffer (50 mM Tris-HCl (pH7), 150 mM NaCl,
and 1% Triton-X100). Whole cell lysates were centrifuged
at 435,000 × gmax for 30 min at 4°C. Total protein concen-
tration was determined by Bradford assay. Cell extracts
were diluted in the appropriate binding buffers for the dif-
ferent chromatographic Protein Chip arrays. Four arrays
types, each with a different binding condition, were used
for profiling the cell lysates. The following binding buffers
were used for washing and protein binding on the arrays:
weak cationic exchange (CM10) with 100 mM NaOAc4,
0.1% Triton X-100; hydrophobic array (H50) with 10%
ACN, 0.1% TFA; strong anion exchange array (Q10) with
50 mM Tris, pH 9.0, 0.1% Triton X-100; and the IMAC Ni
array was activated with 100 mM NiSO4 for 15 min and
used with PBS buffer, 0.1% Triton X-100. Arrays with sam-
ple and peptide/protein molecular weight standards (Bio-
Rad) were analyzed using a PBS IIc ProteinChip Reader
system (Ciphergen Biosystems). For data acquisition, a
mass range of 2 to 150 kDa was captured, with optimisa-
tion range set from 2 to 30 kDa. Spectra were normalized
to TIC and analyzed by the ProteinChip software and
CiphergenExpress software.
Spectra were clustered in CiphergenExpress using the fol-
lowing settings: first pass 5.0 S/N (signal to noise) 3.0 val-
ley depth; minimal peak threshold: 25% of all spectra.;
second pass: 3.0 S/N; 3.0 valley depth. The software was
used to detect peak differences by the Mann-Whitney U
test for nonparametric data sets and the Kruscal-Wallis
test. All spectra were inspected manually to validate peak
differences. p-values were calculated using the Mann-
Whitney U test for non-parametric data sets. The calcula-
tion of intensity ratios and comparison of the groups as
well as hierarchical clustering and heat map analysis were
performed using tools integrated in the CiphergenExpress
software.
Statistical analysis
Statistical computation and estimation of significance
were carried out using unpaired Student's T-test using
Prism4 (GraphPad Software). The computed 2-tailed T-
test p values were considered highly statiscally significant
when p ranges from 0,001 to 0,01 (noted as ** in Fig 2B
and 3A), significant when 0,05 > p > 0,01 (noted as * in
Fig 3B), and not siginificant when p > 0,05. Differences in
peak intensity were evaluated using ANOVA with Fischer's
post hoc test (SELDI-TOF MS, multigroup comparisons).
P-values lower than 0.05 were considered significant.
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